DA agonists ‐ Ergot derivaties: Lisuride
Identifieur interne : 004522 ( Main/Curation ); précédent : 004521; suivant : 004523DA agonists ‐ Ergot derivaties: Lisuride
Auteurs :Source :
- Movement Disorders [ 0885-3185 ] ; 2002-07.
English descriptors
- KwdEn :
- Dopamine Agonists (adverse effects), Dopamine Agonists (pharmacology), Dopamine Agonists (therapeutic use), Drug Therapy, Combination, Ergot Alkaloids (adverse effects), Ergot Alkaloids (pharmacology), Ergot Alkaloids (therapeutic use), Humans, Levodopa (therapeutic use), Lisuride (adverse effects), Lisuride (pharmacology), Lisuride (therapeutic use), Parkinson Disease (drug therapy), Psychomotor Disorders (prevention & control), Randomized Controlled Trials as Topic.
- MESH :
- chemical , adverse effects : Dopamine Agonists, Ergot Alkaloids, Lisuride.
- chemical , pharmacology : Dopamine Agonists, Ergot Alkaloids, Lisuride.
- chemical , therapeutic use : Dopamine Agonists, Ergot Alkaloids, Levodopa, Lisuride.
- drug therapy : Parkinson Disease.
- prevention & control : Psychomotor Disorders.
- Drug Therapy, Combination, Humans, Randomized Controlled Trials as Topic.
Url:
DOI: 10.1002/mds.5565
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002B88
- to stream Istex, to step Curation: Pour aller vers cette notice dans l'étape Curation :002B88
- to stream Istex, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :002E14
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003981
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :003981
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :003B45
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :000870
- to stream Ncbi, to step Curation: Pour aller vers cette notice dans l'étape Curation :000870
- to stream Ncbi, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000870
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :006528
Links to Exploration step
ISTEX:AFC9C727A6DBBFA7AF8708C65F4FE324DE03E366Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">DA agonists ‐ Ergot derivaties: Lisuride</title>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:AFC9C727A6DBBFA7AF8708C65F4FE324DE03E366</idno>
<date when="2002" year="2002">2002</date>
<idno type="doi">10.1002/mds.5565</idno>
<idno type="url">https://api.istex.fr/document/AFC9C727A6DBBFA7AF8708C65F4FE324DE03E366/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002B88</idno>
<idno type="wicri:Area/Istex/Curation">002B88</idno>
<idno type="wicri:Area/Istex/Checkpoint">002E14</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:12211144</idno>
<idno type="wicri:Area/PubMed/Corpus">003981</idno>
<idno type="wicri:Area/PubMed/Curation">003981</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003B45</idno>
<idno type="wicri:Area/Ncbi/Merge">000870</idno>
<idno type="wicri:Area/Ncbi/Curation">000870</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000870</idno>
<idno type="wicri:Area/Main/Merge">006528</idno>
<idno type="wicri:Area/Main/Curation">004522</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">DA agonists ‐ Ergot derivaties: Lisuride</title>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>New York</pubPlace>
<date type="published" when="2002-07">2002-07</date>
<biblScope unit="vol">17</biblScope>
<biblScope unit="issue">S4</biblScope>
<biblScope unit="supplement">4</biblScope>
<biblScope unit="page" from="S74">S74</biblScope>
<biblScope unit="page" to="S78">S78</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">AFC9C727A6DBBFA7AF8708C65F4FE324DE03E366</idno>
<idno type="DOI">10.1002/mds.5565</idno>
<idno type="ArticleID">MDS5565</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Dopamine Agonists (adverse effects)</term>
<term>Dopamine Agonists (pharmacology)</term>
<term>Dopamine Agonists (therapeutic use)</term>
<term>Drug Therapy, Combination</term>
<term>Ergot Alkaloids (adverse effects)</term>
<term>Ergot Alkaloids (pharmacology)</term>
<term>Ergot Alkaloids (therapeutic use)</term>
<term>Humans</term>
<term>Levodopa (therapeutic use)</term>
<term>Lisuride (adverse effects)</term>
<term>Lisuride (pharmacology)</term>
<term>Lisuride (therapeutic use)</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Psychomotor Disorders (prevention & control)</term>
<term>Randomized Controlled Trials as Topic</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Dopamine Agonists</term>
<term>Ergot Alkaloids</term>
<term>Lisuride</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Dopamine Agonists</term>
<term>Ergot Alkaloids</term>
<term>Lisuride</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Dopamine Agonists</term>
<term>Ergot Alkaloids</term>
<term>Levodopa</term>
<term>Lisuride</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Psychomotor Disorders</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Drug Therapy, Combination</term>
<term>Humans</term>
<term>Randomized Controlled Trials as Topic</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004522 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 004522 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Curation |type= RBID |clé= ISTEX:AFC9C727A6DBBFA7AF8708C65F4FE324DE03E366 |texte= DA agonists ‐ Ergot derivaties: Lisuride }}
![]() | This area was generated with Dilib version V0.6.23. | ![]() |